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Chemical Incompatibility of Parenteral
Drug Admixtures
T. J. McCARTHY
SUMMARY
Incompatibilty of parenteral drug admixtures is a subject
with such wide ramifications that the problem of correlating
all the factors will in future probably only be controlled
by computer techniques. In the meantime, a knowledge of
pH factors and a sound reference library, together with a
pre-planned use of drug combinations wherever possible,
will do much to alleviate the problem.
Useful reference articles and facets of pH are discussed.
Consideration should be given to avoiding admixtures of
undocumented drugs in infusion fluids, and use should be
made of a single drug injection at a separate locus.
S. Afr. Med. J., 48, 1951 (1974).
From the USA it is reported that an average of 18 - 20%
of hospitalised patients suffer from adverse drug reactions,
and a patient admitted with a minor injury like a broken
leg stands a reasonable chance of dying from drug com-
binations administered to him. Predicting what will occur
when several drugs are mixed is no easy matter, as can
be seen from the following statistics of the number of
unique combinations caused by mixing numbers of drugs.
Thus 20 drugs mixed 2 at a time, give 190 combinations;
20 drugs mixed 3 at a time, give I 140 combina-
tions;
24 drugs mixed 2, 3 and 4 at a time, give 11 000
combinations;
400 drugs mixed 5 at a time, give 84 million com-
binations.
Jacobs' interviewed 17 hospital departments and found
that 56 drugs and 8 infusion solutions were in routine
intravenous use. Patterson and Nordstrom' estimated that
86% of all infusions administered contained one or more
additives.
Recently I lectured an anaesthetics department on some
of the problems involved in chemical incompatibility
occurring when injectables are mixed, and these problems
are presented, not to discuss pharmacological or clinical
incompatibility, but rather to assist housemen, anaesthetists
and nursing staff with the difficulties of administering safe
parenteral admixtures.
WHAT CONSTITUTES A SAFE ADMIXTURE?
A safe admixture is one that is free from micro-organisms,
free from particulate matter, undecomposed and clinically
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compatible. One method of eliminating both microbial and
particulate matter is to insert a Millipore filter between the
needle and infusion bottle, but this practice is not common
in South Africa. Particulate matter can cause granulomata
(particularly pulmonary) and particles can cause a pyro-
genic reaction---conceivably due to leucocytic damage with
release of endogenous pyrogen.
Just how many particles constitute a haze would be
difficult to define, but it may well be thousands, or even
millions, of small particles per millilitre when one con-
siders that the bacterial count comparator tubes equiva-
lent to 750 million baCterial cells (I - 2 fJ-m in size) per
millilitre are only a 'heavy haze'. Vacolitres containing
30 million glass particles per litre have been found on the
market, and modem requirements demand not more than
10000 (5 fJ-m) particles per litre.
Particularly dangerous are those drugs which precipitate
only slowly (e.g. Gantrisin 4 g in 5°~ aminosol, I - 6 hours,
or diphenylhydantoin sodium in Ringer's with 5,% dextrose,
6 - 24 hours). Tables concerning compatibilities of drugs
used parenterally are freely available in chart form from
both Abbott and Baxter Laboratories. The former lists 35
commonly used injectables and their reactions with the 59
available Abbott's infusion products, also indicating in-
compatibility, and where 'haze' occurs, the time when this
may occur. Baxter's chart lists some 40 drugs in pairs in
various infusions; thus aminophylline is incompatible with
some 16 listed drugs in normal saline, with 18 in 5%
dextrose solution, and with 24 in 3°1c sodium chloride
solution. One cannot easily remember all these incom-
patibilities, but the charts should be available for ready
consultation when intravenous therapy is being used.
In addition to these charts a number of papers have
been published on such incompatibilities. Riley" has pains-
takingly taken 67 commonly used drugs and mixed each in
turn with the other 66, using normal saline and a1so 5%
dextrose (pH 4,3) as the vehicles. The phenothiazine family
was one of the most active, and reacted with sodium and
potassium salts of antibiotics and sodium salts of sul-
phonamides. Heparin formed immediate precipitates with
a number of antibiotics, particularly those used in the
treatment of tuberculosis. Sulphadiazine gave a visible re-
action with a quarter of the substances under test, including
retarded formation of a precipitate, which might not be
noticed after some hours, particularly if it is in a plastic
container. Antibiotics often interact owing to pH changes,
possibly the largest single cause of incompatibility and
potency loss in injectables. When the sodium salt of a
weak acid such as penicillin is mixed with either an acid
solution such as dextrose, or the hydrochloride of a tetra-
cycline, stability loss or precipitation can occur.
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INTRAVENOUS ADDITIVES
TABLE I. DRUG INTERACTIONS IN INTRAVENOUS
INFUSION FLUIDS (AFTER GRAYSON')
DRUGS TO BE USED IMMEDIATELY AFTER
RECONSTITUTION
Other highly reactive drugs are antibiotics, phenothiazine
derivatives, ascorbic acid, morphine derivatives, hydrocortisone,
sodium succinate, heparin, dimenhydrinate and barbiturates.
INTERACTIONS BETWEEN INFUSION
FLUIDS AND DRUGS
responsibility for error from the nursing staff, who, un-
like the pharmacist, have not had the benefit of 4 years
of chemistry, not that a knowledge of chemistry can
anticipate all the reactions that may occur when one or
more drugs are mixed. Thus a list of drugs which must
be used immediately after reconstitution has been sum-
marised as follows: 'Amytal sodium, antivenin (Crotalidal)
polyvalent vial, Ascorbin B (3 hours), Aureomycin intra-
venous, Betolake with C (3 hours), Cathomycin Iyovac vial,
Cosmegen Iyovac, coumadin, Cytoxan (3 hours), Dilantin
(few hours), Dornavac, dried human fibrinogen, fibro-
AHF, Folbesyn, Furadantin sodium, Librium, Luminal
sodium, Manibec-C, Miochol intra-ocular, Mustagen HC!.
novocain, ovogran, Orinase diagnostic (1 hour), Pareno-
gen (I hour), Parlite vitamins B with C, Penbritin-S
(I hour), phenobarbital sodium (t hour), PolyciJlin-N (1
hour), pontocaine HCl niphanoid, Regitine methanesulpho-
nate, Solu-B with ascorbic acid, Solu-zyme with ascorbic
acid, Tham-E (few hours), thrombolysin (2 hours), Urevert,
Vicert C, Viron No. I.
To these may be added the following from Jacobs' -
ampicillin sodium, Ampiclox neonatal, Crystapen, crysta-
mycin, Pyopen, Orbenin and Hyalase Celbenin.
Generalisations that can be made on such interactions
include:
Direct interaction: Tetracycline interacting with cal-
cium salts to form the insoluble salt which precipitates;
Salting out by electrolytes: Amphotericin B, being col-
loidal, is salted out by electrolytes and furthermore is
sensitive to light, losing activity with time of infusion:
Polymerisation: Cephaloridine tends to polymerise at
acid pH and these polymers have been implicated in the
development of hypersensitivity;
Conjugation: Some drugs, e.g. the penicillins, can con-
jugate with the proteins of infusion fluids to form poten-
tial allergens;
pH: Decomposition may occur if a salt of a weak acid
is added to an acidic infusion (e.g. dextrose) or the hydro-
chloride of a weak base is added to an alkaline fluid
(sodium bicarbonate infusion). Epinephrine loses 60% of
its activity immediately on addition to a 5°~ sodium bi-
carbonate solution:
The importance of pH is so great that it warrants
further attention. Both pH and concentration are related
by the well-known Henderson equation.
Incompatible with
A:k:1line solutions, ascorbic acid,
cardiac glycosides, chlorpromazine,
Darrow's solution, heavy metal salts,
hyaluronidase, magnesium salts,
mephentermine, novobiocin, phenira-
mine, sodium chloride solution, tetra-
cycline, Warfarin in 5% dextrose.
Anileridine, ascorbic acid, barbitu-
rates, calcium and magnesium salts,
chlorpromazine, codeine phosphate,
dimenhydrinate, hydralazine, hydroxy-
zine, levorphanol, methadone, mor-
phine sulphate, oxytetracycline, papa-
verine, pethidine, phenytoin, procaine
HCI, prochlorperazine, promazine HCI,
promethazine HCI, strongly acid solu-
tions, vancomycin, vitamin B com-
pounds and preparations.
Methicillin sodium, morphine deriva-
tives, phenytoin, sulphafurazole.
Fibrinolysin, Warfarin sodium.
Alkalis and oxidising agents, barbi-
turates, chlorpheniramine, chlorothia-
zide, nitrofurantoin, novobiocin, pheny-
toin, sodium bicarbonate, sodium
iodide, streptomycin, sulphadiazine,
sulphafurazole.
Aminophylline
(pH 7-9,5)
First drug
Adrenaline (pH 3)
Levallorphen (Lorfan)
(pH 4,3)
Noradrenaline
(Levophed)
(pH 3-4,5)
An excellent review of intravenous additives is that of
Grayson: which runs to 7 pages and obviously cannot
be reproduced in full here. A few examples have been
chosen to show the reactivity of certain drugs, and these
appear in Table I.
Oxytocin
(Syntocinon, Pitocin)
(pH 3-4)
Jacobs' also lists several drugs, particularly the antibiotics,
with notes regarding their stability. A far more compre-
hensive document is that of Latiolais et al.: which covers
hundreds of drugs, their stability, recommended diluent,
etc. They instituted a drug reconstitution service in the
Ohio State Hospital where all parenteral dr:ugs are re-
constituted aseptically (using laminar screens) in the
hospital pharmacy. This removes the tremendous onus of
[Salt]
Thus pH = pKa + log ---
[acid]
Let us consider sodium sulphadiazine 1O~~ solution as'
an example. Reference to tables gives the dissociation of
sulphadiazine (pKa) as 6,3. The solubility of sulphadiazine
is only 1 - 1 300 of water, but sodium sulphadiazine is
soluble 1 - 2 of wat~r. -
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Thus at pH 7,3
(7,3) pH = pKa (6,3) + 10POO] (Salt, Sod. sulphadiazine)
[ 10] (Acid, sulphadiazine)
while at pH 8,3
[100](8,3) pH = 6,3 + log--
[ I ]
[100]
and at pH 9,3 pH = 6,3 + log--
[0,1]
At pH 7,3 there are IQ g/litre of acid present and since the
solubility of the free acid (sulphadiazine) is only 1 - 1 300,
some remains undissolved. At pH 8,3 only 1 g remains, and
will probably just dissolve, and certainly at a more alkaline
pH. It should thus be obvious that if sodium sulphadiazine
solution 10% is added to a solution which brings its pH
below 8,3 it will precipitate. We see similarly that pheno-
barbital has a solubility of only 0,11 % between pH 2 - 6,
but is soluble 0,41'% at pH 8 and 2,9% at pH 10.
However, if we mix two simple unbuffered solutions in
equal volumes, the result is not a simple arithmetic mean
of the two pH values. Thus mixing equal volumes of un-
buffered solutions of pH 4 and 8 produces a pH of 4,3.
Similarly mixing pH 3 and 6 produces 3,3, while pH 8 and
10 produces 9,7. Unfortunately, to complicate matters, in-
jectables, other than infusion fluids, are seldom simple
solutions and can contain preservatives, buffers, stabilisers,
chelating agents like EDTA, and other adjuvants. Unless
these are listed on the injection label one has little hope
of anticipating what will occur on admixture, which in
itself is a strong case against making a potentially harmful
chemical soup in the infusion bottle.
Where possible, a separate locus of injection should be
used. This may inconvenience the patient, but better a
temporarily inconvenienced patient than a permanently
dead one. As Baker' pointed out, it is only in certain cases
that continuous intravenous infusion is required to main-
tain a constant drug level (heparin, lignocaine, potassium
chloride). Where a drip is running, direct intravenous in-
jection via the tubing is preferable for many antibiotics or
vitamins, although concentrated penicillin solutions, being
alkaline, can cause vein damage. However, should imme-
diate precipitation occur, there could be dangerous con-
sequences to the patient, hence the preference for an en-
tirely separate injection site.
CONCLUSION
It is apparent that with the multiplicity of drugs available
only computer techniques will enable a rapid information
retrieval to predict compatibility and stability. Where a
set pattern of drugs is used, then a good reference library
becomes imperative, a good basis for which would be the
references mentioned here. It is felt that the pharmacist's
knowledge could be better used in this connection, parti-
cularly that of the new trainee pharmacist who wishes to
become more clinically orientated, and who has 4 years
of chemistry, 3 years of pharmaceutics and 2 years of
pharmacology in his curriculum. If invited to warcL rounds,
a suitable quid pro quo could surely be arr.>'nged?
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